These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16213192)

  • 1. Adenovirus-mediated gene transfer and lipoprotein-mediated protein delivery of plasma PAF-AH ameliorates proteinuria in rat model of glomerulosclerosis.
    Iso-O N; Noto H; Hara M; Togo M; Karasawa K; Ohashi N; Noiri E; Hashimoto Y; Kadowaki T; Kimura S; Watanabe T; Tsukamoto K
    Mol Ther; 2006 Jan; 13(1):118-26. PubMed ID: 16213192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress.
    Noto H; Hara M; Karasawa K; Iso-O N; Satoh H; Togo M; Hashimoto Y; Yamada Y; Kosaka T; Kawamura M; Kimura S; Tsukamoto K
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):829-35. PubMed ID: 12649088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin.
    Papavasiliou EC; Gouva C; Siamopoulos KC; Tselepis AD
    Nephrol Dial Transplant; 2006 May; 21(5):1270-7. PubMed ID: 16421163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High lipid levels in very low density lipoprotein and intermediate density lipoprotein may cause proteinuria and glomerulosclerosis in aging female analbuminemic rats.
    Joles JA; van Goor H; van der Horst ML; van Tol A; Elema JD; Koomans HA
    Lab Invest; 1995 Dec; 73(6):912-21. PubMed ID: 8558854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome.
    Rizos E; Tambaki AP; Gazi I; Tselepis AD; Elisaf M
    Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):203-9. PubMed ID: 15664305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.
    Quarck R; De Geest B; Stengel D; Mertens A; Lox M; Theilmeier G; Michiels C; Raes M; Bult H; Collen D; Van Veldhoven P; Ninio E; Holvoet P
    Circulation; 2001 May; 103(20):2495-500. PubMed ID: 11369691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine platelet-activating factor acetylhydrolase (PAF-AH) activity related to fertility.
    Turk R; Juretić D; Geres D; Bacić G; Milesević M; Flegar-Mestrić Z; Turk N; Svetina A
    Anim Reprod Sci; 2008 May; 105(3-4):344-53. PubMed ID: 17442508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles.
    Mitsios JV; Vini MP; Stengel D; Ninio E; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1907-13. PubMed ID: 16728656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection.
    Caini P; Guerra CT; Giannini C; Giannelli F; Gragnani L; Petrarca A; Solazzo V; Monti M; Laffi G; Zignego AL
    J Viral Hepat; 2007 Jan; 14(1):22-8. PubMed ID: 17212640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor (PAF) increase intracellular lipid accumulation by increasing both LDL and scavenger receptors in human mesangial cells.
    Fragopoulou E; Iatrou C; Antonopoulou S; Ruan XZ; Fernando RL; Powis SH; Moorhead JF; Varghese Z
    J Lab Clin Med; 2006 Jun; 147(6):281-9. PubMed ID: 16750665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma platelet-activating factor-acetyl hydrolase activity and the levels of free forms of biomarker of lipid peroxidation in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage.
    Hirashima Y; Doshi M; Hayashi N; Endo S; Akazawa Y; Shichiri M; Yoshida Y
    Neurosurgery; 2012 Mar; 70(3):602-9. PubMed ID: 21866060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect.
    Milionis HJ; Tambaki AP; Kanioglou CN; Elisaf MS; Tselepis AD; Tsatsoulis A
    Thyroid; 2005 May; 15(5):455-60. PubMed ID: 15929667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Tat reduces nephrin in human podocytes: a potential mechanism for enhanced glomerular permeability in HIV-associated nephropathy.
    Doublier S; Zennaro C; Spatola T; Lupia E; Bottelli A; Deregibus MC; Carraro M; Conaldi PG; Camussi G
    AIDS; 2007 Feb; 21(4):423-32. PubMed ID: 17301560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proangiogenic phenotype of tumor-derived endothelial cells is reverted by the overexpression of platelet-activating factor acetylhydrolase.
    Doublier S; Ceretto M; Lupia E; Bravo S; Bussolati B; Camussi G
    Clin Cancer Res; 2007 Oct; 13(19):5710-8. PubMed ID: 17908960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma non-esterified fatty acids and platelet-activating factor acetylhydrolase are associated with susceptibility to atherosclerosis in mice.
    Singh U; Zhong S; Xiong M; Li TB; Sniderman A; Teng BB
    Clin Sci (Lond); 2004 Apr; 106(4):421-32. PubMed ID: 14717654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species and platelet-activating factor synthesis in age-related glomerulosclerosis.
    Ruiz-Torres P; Gonzalez-Rubio M; Lucio-Cazaña FJ; Ruiz-Villaespesa A; Rodriguez-Puyol M; Rodriguez-Puyol D
    J Lab Clin Med; 1994 Oct; 124(4):489-95. PubMed ID: 7930874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis.
    De Geest B; Stengel D; Landeloos M; Lox M; Le Gat L; Collen D; Holvoet P; Ninio E
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E68-75. PubMed ID: 11031226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine of patients with nephrotic syndrome contains the plasma type of PAF-acetylhydrolase associated with lipoproteins.
    Balafa OC; Karabina SA; Pappas CA; Elisaf M; Tselepis AD; Siamopoulos KC
    Nephron Physiol; 2004; 97(3):p45-52. PubMed ID: 15292677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease.
    Ninio E; Tregouet D; Carrier JL; Stengel D; Bickel C; Perret C; Rupprecht HJ; Cambien F; Blankenberg S; Tiret L
    Hum Mol Genet; 2004 Jul; 13(13):1341-51. PubMed ID: 15115767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor receptor (PAF-R) and acetylhydrolase (PAF-AH) are co-expressed in immature bovine trophoblast giant cells throughout gestation, but not at parturition.
    Bücher K; Leiser R; Tiemann U; Pfarrer C
    Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):74-83. PubMed ID: 16516811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.